Basic Information
Atonco is a clinical-stage radiopharmaceutical company developing molecularly targeted radiation products for oncology applications. Originating from the world-class nuclear medicine cluster in Nantes, Atonco and its academic partners are dedicated to the clinical application of α-emitting radionuclides.
Atonco
France
unclear
January 01, 2019
--
--